Roxana E. Iacob
Relay Therapeutics (United States) · 70 works · 5,257 citations · h-index 30
Top works
- Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
- Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors
- Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments
- Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors
- Force interacts with macromolecular structure in activation of TGF-β
- Hydrogen/deuterium exchange mass spectrometry for probing higher order structure of protein therapeutics: methodology and applications
- Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6
- Tissue-Specific Oncogenic Activity of KRASA146T
- Applications of Hydrogen/Deuterium Exchange MS from 2012 to 2014
- Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7
- Hydrogen Exchange Mass Spectrometry: Are We Out of the Quicksand?
- Conformational disturbance in Abl kinase upon mutation and deregulation
- Structure and Dynamic Regulation of Abl Kinases*
- Allosteric Interactions between the Myristate- and ATP-Site of the Abl Kinase
- Investigating Monoclonal Antibody Aggregation Using a Combination of H/DX-MS and Other Biophysical Measurements
- Ion mobility adds an additional dimension to mass spectrometric analysis of solution‐phase hydrogen/deuterium exchange
- Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism
- Structural mechanism of a drug-binding process involving a large conformational change of the protein target
- The Natural Product Cucurbitacin E Inhibits Depolymerization of Actin Filaments
- Mass spectrometric characterization of glycosylation of hepatitis C virus E2 envelope glycoprotein reveals extended microheterogeneity of N-glycans